An anonymous director reports

NANALYSIS ANNOUNCES GRANT OF OPTIONS AND RESTRICTED SHARE UNITS

Nanalysis Scientific Corp.'s board of directors has granted 1.21 million restricted share units and 350,000 stock options to certain directors, officers and employees of the company, pursuant to the company's stock option plan and restricted share unit plan, as applicable. Each option is exercisable, once vested, to purchase one common share of the company at 20 cents per share for a period of five years from the date of grant. Each vested RSU entitles the holder to receive one common share.

About Nanalysis Scientific Corp.

Nanalysis develops and manufactures portable nuclear magnetic resonance spectrometers used worldwide in pharma, biotech, energy, food, material and security industries, as well as in academic and government labs. The company also operates a growing service division that maintains both its own products and third party imaging equipment, anchored by a $160-million long-term contract with the Canadian Air Transport Security Authority, to maintain security scanners at more than 80 Canadian airports.

We seek Safe Harbor.